about
Structural insights into aldosterone synthase substrate specificity and targeted inhibitionEndothelial cells expressing low levels of CD143 (ACE) exhibit enhanced sprouting and potency in relieving tissue ischemia.The past, present and future of renin-angiotensin aldosterone system inhibitionRenalase's expression and distribution in renal tissue and cellsDiscovery of inhibitors of insulin-regulated aminopeptidase as cognitive enhancers.A Novel Cellular Model to Study Angiotensin II AT2 Receptor Function in Breast Cancer CellsDual agonist occupancy of AT1-R-α2C-AR heterodimers results in atypical Gs-PKA signalingProtective effect of olmesartan against cardiac ischemia/reperfusion injury in spontaneously hypertensive ratsNontraditional roles of angiotensin-converting enzyme.The association study on renalase polymorphism and hypertension: a meta-analysis.Association of high pulse pressure with proteinuria in subjects with diabetes, prediabetes, or normal glucose tolerance in a large Japanese general population sampleNADPH oxidase-derived H(2)O(2) contributes to angiotensin II-induced aldosterone synthesis in human and rat adrenal cortical cellsThe Angiotensin II Type 2 Receptor in Brain Functions: An Update.Comorbid Heart Failure and Renal Impairment: Epidemiology and Management.Antihypertensive and Antihypertrophic Effects of Acupuncture at PC6 Acupoints in Spontaneously Hypertensive Rats and the Underlying Mechanisms.Blood pressure and renal hemodynamic effects of angiotensin fragments.Local ocular renin-angiotensin system - a target for glaucoma therapy?Stroke, high blood pressure and the Renin-Angiotensin-aldosterone system - new developments.Emerging drugs which target the renin-angiotensin-aldosterone system.Therapeutic perspectives in hypertension: novel means for renin-angiotensin-aldosterone system modulation and emerging device-based approaches.Current challenges in the clinical management of hypertension.Are there new threshold and goals in the treatment of arterial hypertension?Key advances in antihypertensive treatment.Particle therapy for noncancer diseases.The renin-angiotensin system, bone marrow and progenitor cells.Prevention of coronary artery disease: recent advances in the management of hypertension.Aldosterone synthase inhibition in hypertension.Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors.New developments in the pharmacological treatment of hypertension: dead-end or a glimmer at the horizon?Nanocarriers as treatment modalities for hypertension.Mega clinical trials which have shaped the RAS intervention clinical practice.PHYSIOLOGY AND ENDOCRINOLOGY SYMPOSIUM: Insulin action and lipotoxicity in the development of polycystic ovary syndrome: A review.The adipose tissue and the involvement of the renin-angiotensin-aldosterone system in cardiometabolic syndrome.Development, evaluation, and influence of formulation and process variables on in vitro performance of oral elementary osmotic device of atenolol.Many Faces of Renin-angiotensin System - Focus on Eye.The expression of Mas-receptor of the renin-angiotensin system in the human eye.Effect of a stable Angiotensin-(1-7) analogue on progenitor cell recruitment and cardiovascular function post myocardial infarction.Expression and tissue localization of renalase, a novel soluble FAD-dependent protein, in reproductive/steroidogenic systems.Mineralocorticoid receptor antagonist in heart failure: Past, present and future perspectives.Up-regulation of myocardial connexin-43 in spontaneously hypertensive rats fed red palm oil is most likely implicated in its anti-arrhythmic effects.
P2860
Q24309370-259BB198-46D8-46E3-A46A-C140C22AA64AQ33779325-74C33576-4C31-47DE-9592-8A31D239AFD8Q34094354-D84C91D6-4FD4-4D38-A888-9E49DACEAE67Q34441465-7F00433D-0DAC-4DFC-8560-DD8A20DE4365Q34543485-7CDFC16B-D218-4F31-8BB3-205A4A75FFFCQ35609097-65EEEFC1-1522-47C0-B0A5-BFB5997B124CQ35738220-6E69D993-3B69-4B6F-9A07-06AFF7A838EDQ35758707-CFF54D1A-9852-4BCA-B054-981554150523Q35836666-CF2DFF36-4031-4A2F-B518-8F489D80E231Q35958701-80F8E37C-1D84-47B9-88F4-E73323B3D5A6Q35976460-F7BA1D84-6B1F-4EA2-89D8-271404A84174Q36001842-E208E679-0B61-465B-A851-F7DE595CCC4FQ36520049-299FBBEC-93F7-4E45-959E-CC8F83CDD505Q36551356-7F91FCC5-757A-4807-BCCA-6B44E03B8935Q37672775-331A8321-DD9C-4DAE-A723-33CB752CD96FQ37853834-DCE95823-8195-4E37-9365-8EEB3BE1A894Q37877783-853AA395-B2A3-459F-AB21-17046D6F3116Q37891794-2D2D2BAC-3B2F-4B09-8D7F-1E536B023BF1Q37929786-5E99D0B4-740E-4152-A447-A5A4FF0E76F1Q37939427-0893558C-08E6-4F7B-AB59-ECFE8300C2AAQ37949514-592EECF5-F116-4B67-B39B-4F540F63A7A4Q37992171-093B4B68-86EF-458B-A1A5-D2460781FB58Q37995074-49BF56B2-79D7-46D1-A226-03B9483C7D0CQ38000635-1DB53D45-81AF-492A-9994-7C6E1981F57DQ38006725-B6E948FC-1F37-40B2-8F64-13B72CFE546DQ38075808-AD8CD418-CA9A-4FA2-9135-E66F4614AA77Q38126805-EB83D649-B634-423A-BECF-42A7BCA30E69Q38217456-DF7A6E32-6D94-4AD5-814F-DE6431947960Q38429870-ECBAA4E8-F2DB-48D1-A4B3-71D68599546DQ38760963-B7A26F71-BE78-44DD-BE0E-CEDB9E70C9D5Q38857792-B18B530A-7712-4FF6-9AC7-3A5E0FA44427Q38861206-64BD8B44-0EEA-49B8-8194-90DDE7FCBC54Q38979226-4C662FE9-6449-4F9B-A4F8-BDBA2A1697D1Q40464098-09F2BE60-E923-4F7E-B5B6-EAD4A34E9F32Q41015495-AB693F18-2FF7-456F-82C9-AD34491E3147Q41662750-B44C8310-ECBB-4631-A31B-D51DFD8BB6CCQ43169811-2F3556EA-8F72-413E-9E36-BE65CD0C5B6CQ48633745-F3B9B8B3-2046-4146-AD4B-A31E3380429DQ50143463-BD39EBC3-76E6-438C-BF15-9059D154D9CAQ50504920-A6A6EE95-E481-4B6E-A616-04C69EE49D65
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Novel therapeutic targets for hypertension.
@en
Novel therapeutic targets for hypertension.
@nl
type
label
Novel therapeutic targets for hypertension.
@en
Novel therapeutic targets for hypertension.
@nl
prefLabel
Novel therapeutic targets for hypertension.
@en
Novel therapeutic targets for hypertension.
@nl
P2860
P356
P1476
Novel therapeutic targets for hypertension.
@en
P2860
P304
P356
10.1038/NRCARDIO.2010.85
P407
P577
2010-06-22T00:00:00Z